Women's Health

Use of aspirin failed to prolong invasive DFS among patients with breast cancer, according to results of a randomized phase 3 study presented during the ASCO Plenary Series.

In 2019, most U.S. women who gave birth did not have favorable cardiometabolic health before pregnancy, researchers reported in a Go Red for Women spotlight edition of Circulation.

Breast cancer has surpassed lung cancer as the leading cause of cancer-associated death among Black women in the U.S., according to an American Cancer Society report.

Selinexor prolonged PFS compared with placebo among women with advanced or recurrent endometrial cancer, according to topline data released by the agent’s manufacturer.

Trametinib should be a new standard of care for women with recurrent low-grade serous carcinoma, according to study published in The Lancet that showed a 52% reduction in risk for disease progression or death vs. current treatment options.

The more steps that older women took per day, the more they lowered their risk for developing type 2 diabetes, according to findings published in Diabetes Care.

Balstilimab plus zalifrelimab demonstrated promising and durable activity among women with recurrent and/or metastatic cervical cancer who relapsed after platinum-based therapy, according to a phase 2 study in Journal of Clinical Oncology.

Updates to the Affordable Care Act preventive health care guidelines will require coverage of certain screening and preventive measures for women and children, HHS said.

Women who viewed themselves as lower in socioeconomic status experienced a higher allostatic load 1 year after giving birth, which may lead to worse health outcomes in the future, according to findings published in Health Psychology.

The FDA granted priority review to fam-trastuzumab deruxtecan-nxki for treatment of certain patients with advanced breast cancer.